Partner Therapeutics Competitors and Similar CompaniesClear all

Halozyme Therapeutics's competitors and similar companies include OncoTherapy Science.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
OncoTherapy Science
OncoTherapy Science
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
Founding Date
Founding Date
1998
Founding Date
2001
Type
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Kawasaki, JP HQ
Employees
Employees
373157% increase
Employees
54
Valuation ($)
Valuation ($)
6.4 b
Valuation ($)
56.9 m

Financial

Revenue (est.)
Revenue (est.)
$1.4b (FY, 2025)
Revenue (est.)
¥808.5m (FY, 2026)
Cost of goods
Cost of goods
$228.8m (FY, 2025)
Cost of goods
¥794.6m (FY, 2026)
Gross profit
Gross profit
$1.2b (FY, 2025)
Gross profit
¥14m (FY, 2026)
Net income
Net income
$316.9m (FY, 2025)
Net income
(¥910.6m) (FY, 2026)
For sources of this data, please see the company profile

View Company Profiles

OncoTherapy Science
HQ
Kawasaki, JP
Employees
54

OncoTherapy Science is a company engaged in research and development of cancer therapeutics.

View company